JMDC Inc. (4483) AI Stock Analysis

• Market Cap: ¥294.98B
• Dividend Yield: 0.35%
• Average Volume (3M): 301.82K
• Price to Earnings (P/E): 48.0
• Beta (1Y): 0.78
• Revenue Growth: 20.55%
• EPS Growth: 48.62%
• Country: JP
• Employees: 1,773
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 21.56
• Shares Outstanding: 65,407,005
• 10 Day Avg. Volume: 423,350
• 30 Day Avg. Volume: 301,816
• PEG Ratio: 0.45
• Price to Book (P/B): 2.31
• Price to Sales (P/S): 4.32
• P/FCF Ratio: 14.35
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥5,700.00
• Price Target Upside: 21.35% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: ¥5,368.00 ▲(14.29% Upside)

JMDC Inc. has a strong financial foundation with consistent revenue growth and solid profitability margins, which are the most significant factors contributing to the score. The technical analysis supports a positive trend, although valuation concerns due to a high P/E ratio and low dividend yield slightly offset the overall score.

JMDC Inc. Business Overview & Revenue Model

Company Description

JMDC Inc. (4483) is a leading company in the healthcare sector, primarily focused on providing data analytics and technology solutions. The company specializes in health data management, offering services that include healthcare big data analysis, consulting, and support for insurance claims processing. JMDC Inc. aims to improve healthcare efficiency and outcomes through its innovative products and services, which cater to both healthcare providers and insurance companies.

How the Company Makes Money

JMDC Inc. generates revenue through several key streams, including subscription fees for its data analytics platform, consulting services, and partnerships with healthcare organizations and insurance companies. The subscription model allows clients to access JMDC's comprehensive health data analytics tools, which help them make informed decisions based on real-time data. Additionally, JMDC earns income by providing tailored consulting services to optimize healthcare operations and improve patient outcomes. Significant partnerships with various healthcare stakeholders further enhance JMDC's revenue potential, as they often lead to collaborative projects and expanded service offerings.

JMDC Inc. Financial Statement Overview

Summary

JMDC Inc. exhibits strong financial performance with consistent revenue growth and solid profitability margins. The balance sheet is stable with manageable leverage, although the recent decline in free cash flow growth warrants attention. Overall, the company is well-positioned in the healthcare information services industry.

Income Statement

JMDC Inc. demonstrates strong revenue growth with a TTM increase of 5.52%, supported by healthy gross and net profit margins of 57.16% and 17.43%, respectively. The EBIT and EBITDA margins are robust at 20.94% and 27.63%, indicating efficient operational management. The company has consistently grown its revenue over the years, showcasing a positive growth trajectory.

Balance Sheet

The balance sheet reflects a stable financial position with a moderate debt-to-equity ratio of 0.60, indicating manageable leverage. The return on equity is decent at 9.88%, suggesting effective use of equity to generate profits. The equity ratio stands at 52.23%, highlighting a solid equity base relative to total assets.

Cash Flow

Cash flow analysis reveals a decline in free cash flow growth by 17.14% in the TTM, which could be a concern. However, the operating cash flow to net income ratio is healthy at 1.62, and the free cash flow to net income ratio is strong at 85.57%, indicating good cash generation relative to profits.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	44.02B	41.72B	32.38B	27.81B	21.81B	16.77B
Gross Profit	24.65B	23.85B	19.25B	15.86B	12.59B	9.62B
EBITDA	12.06B	11.53B	9.23B	7.98B	6.51B	4.88B
Net Income	7.51B	7.28B	4.61B	4.27B	3.25B	2.48B
Balance Sheet
Total Assets	149.48B	143.02B	122.45B	98.57B	62.06B	57.85B
Cash, Cash Equivalents and Short-Term Investments	35.63B	32.18B	14.47B	22.78B	13.19B	19.90B
Total Debt	53.83B	46.89B	37.83B	20.40B	17.80B	19.45B
Total Liabilities	70.98B	64.54B	51.77B	34.04B	30.89B	29.60B
Stockholders Equity	78.05B	78.02B	70.59B	64.54B	31.18B	28.25B
Cash Flow
Free Cash Flow	10.41B	12.57B	-2.27B	2.12B	2.49B	952.00M
Operating Cash Flow	12.15B	14.69B	-17.00M	4.06B	3.81B	3.18B
Investing Cash Flow	-7.01B	-3.47B	-24.86B	-22.77B	-8.10B	-9.08B
Financing Cash Flow	12.62B	6.48B	16.58B	28.30B	-2.41B	18.11B

JMDC Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 4697.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4483, the sentiment is Neutral. The current price of 4697 is below the 20-day moving average (MA) of 4739.30, above the 50-day MA of 4567.74, and above the 200-day MA of 3757.33, indicating a neutral trend. The MACD of 49.72 indicates Positive momentum. The RSI at 41.77 is Neutral, neither overbought nor oversold. The STOCH value of 45.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4483.

JMDC Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥21.00B	18.32	―	1.93%	-6.29%	-22.25%
4483	74 Outperform	¥294.98B	47.95	―	0.35%	20.55%	48.62%
2175	68 Neutral	¥118.03B	15.26	―	2.11%	7.27%	13.49%
4480	61 Neutral	€69.79B	48.02	8.00%	―	34.77%	-46.50%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
3902	43 Neutral	¥17.43B	-23.82	―	1.44%	-0.58%	-260.22%

JMDC Inc. Corporate Events

JMDC Inc. Reports Strong Q1 2025 Financial Growth

JMDC Inc. reported significant financial growth for the first quarter ending June 30, 2025, with a 32.5% increase in revenue and a 48.8% rise in operating profit compared to the same period last year. This growth reflects the company’s strategic focus on its core operations after discontinuing its dispensing pharmacy support business, enhancing its market positioning and potentially increasing shareholder value.

The most recent analyst rating on (JP:4483) stock is a Buy with a Yen4800.00 price target. To see the full list of analyst forecasts on JMDC Inc. stock, see the JP:4483 Stock Forecast page.